Potential bioreductive alkylating agents. 2. Antitumor effect and biochemical studies of naphthoquinone derivatives - PubMed (original) (raw)

Potential bioreductive alkylating agents. 2. Antitumor effect and biochemical studies of naphthoquinone derivatives

A J Lin et al. J Med Chem. 1973 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• Potential bioreductive alkylating agents. 4. Inhibition of coenzyme Q enzyme systems by lipoidal benzoquinone and naphthoquinone derivatives.
  Lin AJ, Pardini RS, Lillis BJ, Sartorelli AC. Lin AJ, et al. J Med Chem. 1974 Jul;17(7):688-7. J Med Chem. 1974. PMID: 4151966 No abstract available.
• Potential bioreductive alkylating agents. 1. Benzoquinone derivatives.
  Lin AJ, Cosby LA, Shansky CW, Sartorelli AC. Lin AJ, et al. J Med Chem. 1972 Dec;15(12):1247-52. doi: 10.1021/jm00282a011. J Med Chem. 1972. PMID: 4635968 No abstract available.
• 2- and 6-methyl-1,4-naphthoquinone derivatives and potential bioreductive alkylating agents.
  Antonini I, Lin TS, Cosby LA, Dai YR, Sartorelli AC. Antonini I, et al. J Med Chem. 1982 Jun;25(6):730-5. doi: 10.1021/jm00348a023. J Med Chem. 1982. PMID: 7097727
• [Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase].
  Belousova AK. Belousova AK. Vopr Onkol. 1972;18(8):88-96. Vopr Onkol. 1972. PMID: 4348595 Review. Russian. No abstract available.
• Biochemical aspects of drug combinations.
  Brockman RW. Brockman RW. Cancer Chemother Rep 2. 1974 Mar;4(1):115-29. Cancer Chemother Rep 2. 1974. PMID: 4135108 Review. No abstract available.

Cited by

• Recent Advances in the Application of Nitro(het)aromatic Compounds for Treating and/or Fluorescent Imaging of Tumor Hypoxia.
  Anichina K, Lumov N, Bakov V, Yancheva D, Georgiev N. Anichina K, et al. Molecules. 2024 Jul 25;29(15):3475. doi: 10.3390/molecules29153475. Molecules. 2024. PMID: 39124883 Free PMC article. Review.
• Physicochemical Considerations of Tumor Selective Drug Delivery and Activity Confinement with Particular Reference to 1,2-Bis(Sulfonyl)-1- Alkylhydrazines Delivery.
  Penketh P, Williamson H, Shyam K. Penketh P, et al. Curr Drug Deliv. 2020;17(5):362-374. doi: 10.2174/1567201817666200427215044. Curr Drug Deliv. 2020. PMID: 32342817 Free PMC article.
• Hypoxia and radiation therapy: past history, ongoing research, and future promise.
  Rockwell S, Dobrucki IT, Kim EY, Marrison ST, Vu VT. Rockwell S, et al. Curr Mol Med. 2009 May;9(4):442-58. doi: 10.2174/156652409788167087. Curr Mol Med. 2009. PMID: 19519402 Free PMC article.
• Comparison of the cytotoxic effect of lapachol, alpha-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells.
  Salustiano EJ, Netto CD, Fernandes RF, da Silva AJ, Bacelar TS, Castro CP, Buarque CD, Maia RC, Rumjanek VM, Costa PR. Salustiano EJ, et al. Invest New Drugs. 2010 Apr;28(2):139-44. doi: 10.1007/s10637-009-9231-y. Epub 2009 Mar 4. Invest New Drugs. 2010. PMID: 19255723
• 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.
  Seow HA, Penketh PG, Shyam K, Rockwell S, Sartorelli AC. Seow HA, et al. Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9282-7. doi: 10.1073/pnas.0409013102. Epub 2005 Jun 17. Proc Natl Acad Sci U S A. 2005. PMID: 15964988 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations